【Nasal Care】Nasal Sprays Show Promise in Reducing Duration of Respiratory Infections, Landmark UK Study Finds | OEM/ODM & Private-Label Healthcare Supply for Hospitals & Retail - Hannox

【Nasal Care】Nasal Sprays Show Promise in Reducing Duration of Respiratory Infections, Landmark UK Study Finds | Medical and Home-Care OEM/ODM – Private-Label Sourcing - Hannox

Menu

New Product

【Nasal Care】Nasal Sprays Show Promise in Reducing Duration of Respiratory Infections, Landmark UK Study Finds | Medical & Home-Care OEM/ODM Supplier – Private Label - Hannox

Hannox International Corp. is a medical device OEM/ODM and global sourcing partner for blood glucose meters and strips, wound-care dressings, natural mosquito repellents, dental units, and home-care devices. We help hospitals, clinics, distributors, and retailers launch accurate, safe, easy-to-use products.

We manage end-to-end private-label projects—selection, customization, branding and packaging, labeling/IFU, QA/QC, and compliance documentation (ISO/CE where applicable)—through a vetted network of partner factories. Expect clear MOQs, predictable lead times, and consistent quality across diabetes care, wound care, dental, and home-care categories.

Hannox delivers high-quality home-care and patient-monitoring devices, backed by advanced technology and 22 years of expertise. We support OEM/ODM and private-label sourcing—selection, customization, packaging, and compliance—so professional buyers launch standards-ready products fast.

【Nasal Care】Nasal Sprays Show Promise in Reducing Duration of Respiratory Infections, Landmark UK Study Finds

A major study published in The Lancet Respiratory Medicine (August 2024) has revealed that simple nasal sprays may help reduce the duration and severity of acute respiratory infections (ARIs) when used at the first signs of illness.

Respiratory

Conducted across 332 primary care practices in the UK and involving 13,799 participants, this is the largest trial to date assessing preventive and early interventions for respiratory infections in community healthcare. The study compared conventional treatment with two nasal spray options—saline solution spray and gel-based spray—administered at the onset of respiratory symptoms.

The findings were clear: both types of nasal sprays shortened the illness by an average of three days compared to routine care. They also reduced symptom intensity and significantly lowered the use of antibiotics. Researchers noted that the benefit largely came from washing the nasopharyngeal area, which reduced viral load and helped the body recover faster.

Experts recommend that nasal sprays be used as soon as early symptoms appear. If widely adopted, this low-cost, easy-to-use intervention could play a crucial role in antibiotic stewardship, helping to reduce unnecessary prescriptions while easing the burden of viral respiratory diseases on patients, healthcare systems, and the broader economy.

Related Products
  • Nose Liquid Bandage Spray - nasal spray
    Nose Liquid Bandage Spray
    HX-N12

    Nose Liquid Bandage Spray helps to relieve the pain of nasal mucosa wounds caused by head and neck radiotherapy. The symptoms of atrophic rhinitis (Ozena), chronic sinusitis, nasal dryness and viscous nasal mucus can also be relieved. Provide moisture and clean the nasal cavity.